Company Registration No. 13040599 (England and Wales)
Molomix Bioscience Limited
Unaudited accounts
for the year ended 30 November 2024
Molomix Bioscience Limited
Unaudited accounts
Contents
Molomix Bioscience Limited
Company Information
for the year ended 30 November 2024
Directors
Dr Luke Stephen Midgley
Nigel David Pickett
Simon Alexander Pickett
Company Number
13040599 (England and Wales)
Registered Office
Three Trees
Waterton Lane
Bridgend
CF31 3YW
Accountants
Evans Entwistle
Villa House
7 Herbert Terrace
Penarth
Vale of Glamorgan
CF64 2AH
Chartered Management Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of
Molomix Bioscience Limited
for the year ended 30 November 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Molomix Bioscience Limited for the year ended 30 November 2024 which comprise of the Profit and Loss Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.
As a CIMA Registered Member in Practice and Practising Certificate holder, I am subject to its ethical and other professional requirements which are detailed at https://www.cimaglobal.com/Members/Your-Membership-Information/Members-handbook/Licensing-and-monitoring/Members-in-practice/
Our work has been undertaken in accordance with the requirements of the Chartered Institute of Management Accountants as detailed at http://www.cimaglobal.com.
Evans Entwistle
Member in Practice
Villa House
7 Herbert Terrace
Penarth
Vale of Glamorgan
CF64 2AH
5 August 2025
Molomix Bioscience Limited
Statement of financial position
as at 30 November 2024
Called up share capital not paid
-
5
Cash at bank and in hand
398
926
Creditors: amounts falling due within one year
(1,923)
(480)
Net current (liabilities)/assets
(1,525)
446
Total assets less current liabilities
(1,525)
451
Creditors: amounts falling due after more than one year
-
(805)
Net liabilities
(1,525)
(354)
Called up share capital
200
200
Profit and loss account
(1,725)
(554)
Shareholders' funds
(1,525)
(354)
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 5 August 2025 and were signed on its behalf by
Simon Alexander Pickett
Director
Company Registration No. 13040599
Molomix Bioscience Limited
Notes to the Accounts
for the year ended 30 November 2024
Molomix Bioscience Limited is a private company, limited by shares, registered in England and Wales, registration number 13040599. The registered office is Three Trees, Waterton Lane, Bridgend, CF31 3YW.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Allotted, called up and fully paid:
200 Ordinary shares of £1 each
200
200
5
Average number of employees
During the year the average number of employees was 0 (2023: 0).